|
|
|
|
|
|
|
24.06.26 - 14:42
|
InMode Confirms Receipt of Unsolicited Proposal (PR Newswire)
|
|
|
YOKNEAM, Israel, June 24, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) (the "Company") today announced that, on June 17, 2026, its Board of Directors (the "Board") received an unsolicited proposal from M.N. Business Strategy, Ltd. ("MN Business Strategy") to acquire through a merger......
|
|
|
|
|
13.05.26 - 14:33
|
InMode to Present at Upcoming Investor Conferences and Events (PR Newswire)
|
|
|
YOKNEAM, Israel, May 13, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events: Barclays Virtual West Coast Bus Trip Presenters: Yair Malca, Outgoing......
|
|
|
|
|
|
|
13.04.26 - 13:03
|
InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M (PR Newswire)
|
|
|
Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for......
|
|
|
|
|
|
|
|
|
13.03.26 - 12:03
|
InMode Announces New Share Repurchase Program (PR Newswire)
|
|
|
YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares......
|
|
|
|
|
23.02.26 - 16:36
|
InMode (INMD) Stock Slips As Board Ends Review (Benzinga)
|
|
|
Shares of InMode Ltd (NASDAQ: INMD) are trading lower Monday morning after the Israeli medical technology company said a special independent transaction committee has ended its strategic review without pursuing any deal.
Importance Rank:
1
read more...
|
|
|
|
|
|
|
|
|
|
|
|
|
|